KYNB

1.56014.75%
DD

David DeLucia

Senior VP & CFO

Mr. David DeLucia has served as Chief Financial Officer since December 16, 2024 and served as Vice President of Corporate FP&A and Investor Relations at Kyntra Bio, Inc. (formerly known as FibroGen, Inc.) until December 2024 having joined in May 2022 and serves as its Senior Vice President. He was Director of Business Development of TherapeuticsMD, Inc. since June, 2018. Mr. DeLucia served as Director of Investor Relations at TherapeuticsMD, Inc. from April, 2016 to June, 2018. He has Bachelor of Business Administration in Finance & Accounting and Bachelor of Science in Economics from the University of Michigan - Stephen M. Ross School of Business.

Positions